During the pandemic, drg. Collins in creating a project, including partnerships and collaborations with pharmaceutical and biotechnology companies, to enable multiple studies of antivirals and other Covid-19 therapies to be conducted simultaneously. Yes.
Some scientists and public health experts say that those that ultimately don’t show strong results, such as convalescent plasma and hydroxychloroquine, are preferred to more rigorous studies of Covid-19 treatments. He criticized the federal government’s research efforts.
dr. H. Clifford Lane, clinical director for the Department of Allergy and Infectious Diseases at the NIH, said Dr. H. Clifford Lane. Collins is making good progress in the chaotic research environment to investigate more promising therapies, including remdezivir and monoclonal antibodies. He said he was quick to mobilize NIH resources.
dr. Forch said dr. Collins is taking an important step from his experience into the broader pandemic response. He said, “This is basically a geneticist getting someone whose disease is related to cystic fibrosis and progeria and is proving to be a valuable partner in infectious disease, pandemics and public health. That’s really special. ”
dr. Collins nearly resigned early last year, said Dr. forch. One night he visited Dr. Forch in his office, admits that for personal reasons he was thinking of leaving. “I asked him not to resign,” said dr. forch. If I retreat, I don’t know who will go up. So we need you with us. Don’t go now. And he understands that. ”
dr. Collins has a PhD. I got my PhD in physical chemistry from Yale University in 1974, but decided that molecular biology was more interesting. He spent many years in the new training. He also wanted to become a doctor and received a PhD in medicine from the University of North Carolina.
He didn’t grow up with religion, but when Dr. Collins asks if he believes in God, he finds he doesn’t. He began to read a lot and was convinced by the writer and theologian CS Lewis, who stated that belief can be a rational choice. At the age of 27 he became a non-denominational evangelical Christian.